Suchergebnisse - Ambrose CS

Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types von Panettieri R Jr, Lugogo N, Corren J, Ambrose CS

Volltext

Mortality Among Adults with Subspecialist-Treated Severe Asthma: A Descriptive Analysis from the Observational CHRONICLE Study von Lugogo NL, Trevor J, Spahn JD, Panettieri RA Jr, Carstens DD, Ambrose CS

Volltext

Quality of Life Improvements with Biologic Initiation Among Subspecialist-Treated US Patients with Severe Asthma von Soong W, Chipps BE, Carr W, Trevor J, Patel A, Clarke N, Carstens DD, Ambrose CS

Volltext

Reduced Effectiveness of Anti-IgE Treatment Among Adults with Severe Asthma with Older Age of Asthma Onset: Results from the CHRONICLE Study von Ledford DK, Carr WW, Moore WC, Lugogo NL, Mohan A, Chipps B, Mackie AR, Lindsley AW, Spahn J, Ambrose CS

Volltext